Removing immune ‘brake’ improves CAR T–cell therapy for osteosarcoma (IMAGE)
Caption
Co-corresponding authors Stephen Gottschalk, MD, St. Jude Department of Bone Marrow Transplantation & Cellular Therapy chair, and Hongbo Chi, PhD, St. Jude Department of Immunology chair, St. Jude Center of Excellence for Pediatric Immuno-Oncology (CEPIO) co-directors.
Credit
Courtesy of St. Jude Children's Research Hospital
Usage Restrictions
none
License
Original content